Objective: To evaluate an electroencephalography (EEG)-based index, the Cerebral Health Index in babies (CHI/b), for identification of neonates with high Sarnat scores and abnormal EEG as markers of hypoxic ischemic encephalopathy (HIE) after perinatal asphyxia.
Introduction
Perinatal asphyxia occurs in 3 per 1000 live term newborns, and it is responsible for 19% of the 5 million neonatal deaths per year worldwide. 1 The injury occurs primarily in the central nervous system, resulting in hypoxic ischemic encephalopathy (HIE), which is responsible for a significant proportion of non-progressive neurological deficits in children. [1] [2] [3] Although current management is limited to supportive therapy, several strategies to minimize post-asphyxia morbidity are under investigation. [4] [5] [6] [7] [8] [9] [10] [11] [12] Hypothermia has been investigated in randomized controlled trials with apparent neuroprotective benefit in term infants with HIE. In order to be effective, hypothermia must be initiated within a maximum of 6 h after birth, with earlier initiation being associated with better outcome. 6, [11] [12] [13] However, early evaluation of the infant's neurological status and evolving response to HIE remains a bedside challenge. To date, bedside electroencephalography (EEG), particularly amplitudeintegrated EEG (aEEG) systems, have been used with good sensitivity and specificity in the prediction of infants with later neurodevelopmental disability. 14, 15 However, clinicians still find that training in the interpretation of aEEG is somewhat challenging.
Thus, a unified 'score' for cerebral health using multiple components of the EEG was sought. We called this multiparametric EEG-based index, the cerebral health index in babies (CHI/b). This index incorporates spectral, probabilistic and temporal aspects of the raw EEG into a single unified measure. These aspects of the EEG include conventionally used features such as the power spectrum and spectral edge frequency, and novel features, including the entropy, volatility and sub-band spectral entropy. Each feature in the final multiparametric feature set was specifically selected to correspond to a spectral or temporal change in the EEG, which in turn was associated with the level of brain injury. Thus, although a single feature may not be very effective independently in the quantification of ischemic brain injury, the CHI/b draws on the strengths of each individual feature and combines them into a powerful algorithm to identify brain injury.
In this study, we compared the CHI/b score, as derived from the quantitative EEG, with two clinical measures of the severity of HIE in the neonate, Sarnat scores and visually interpreted EEG (normal, mildly abnormal and severely abnormal). We hypothesized that the CHI/b score is associated with each of these clinical measures.
Methods CHI/b was evaluated using a retrospective raw EEG data set from 20 term neonates with HIE after perinatal asphyxia and 20 healthy term controls. The data were obtained from BrainZ Instruments (Auckland, New Zealand), and were collected under appropriate institutional review board and human subjects research guidelines.
Clinical protocol
All the newborns underwent bedside EEG monitoring with a 2-channel monitor BrainZ Instruments' BRM2 monitor (Channel 1 (left) C 3 -O 1 and Channel 2 (right) C 4 -O 2 ). The diagnosis of HIE was made clinically by the attending physician, and was based on the presence of perinatal distress, diminished fetal movements, cardiotocographic abnormalities, fetal acidosis, meconium staining of the amniotic fluid, low Apgar scores and the need for neonatal resuscitation. The stage of encephalopathy was graded for all the neonates with HIE using the maximum-modified Sarnat clinical classification within 72 h of life. Neonates with stage 1 HIE showed hyperalertness, hyper-reflexia, tachycardia, jitteriness and dilated pupils. Neonates with stage 2 HIE were lethargic, with a bradycardia, hypotonia, constricted pupils, weak suck, poor Moro response and seizures. Neonates with stage 3 HIE showed stupor, flaccidity, hypotonia, hyper-reflexia, and absent suck, gag and Moro reflexes, central respiratory depression with a need for mechanical ventilation, and seizures.
Preparation of outcome measures for calibration of CHI/b Sarnat scores. A scale from 0 to 1 was used, assuming a linear relationship between Sarnat score and CHI/b. To include the controls in the training process, they were assigned a CHI/b score of 1.0; Sarnat 1 was assigned a score of 0.75; Sarnat 2 was assigned 0.5; and Sarnat 3 was assigned 0.25.
Visual EEG grading. The entire 30-min EEG record from the neonates enrolled in the study was visually graded by a trained expert electroencephalographer blinded to the clinical status of the babies. The electroencephalographer classified the EEGs into one of the three categories (normal, mild abnormality or severe abnormality) based on the background EEG pattern. The following features of the EEG were considered to classify the EEG:
Normal: normal background ± interictal spikes of low frequency (CHI/b ¼ 1.0) Mild abnormality: any discontinuous background activity lasting >2 min, X3 epochs of 10-s duration with high-frequency interictal spikes, recurrent spike discharge lasting between 1 and 9.9 s (CHI/b ¼ 0.5) Severe abnormality: presence of any seizure or >2 min of continuous low-voltage or burst-suppression pattern (CHI/b ¼ 0.0).
Training of CHI/b
From the 30-min EEG recording, a 10-min continuous segment of raw EEG data from Channel 1 was selected for each neonate in the HIE and control groups. The segment was selected to be as free as possible from artifacts to minimize its effect on the training process. In addition, the segments were selected to be free of all recognized seizures. Each segment was divided into 4-s windows and the multiparametric feature set was calculated for each window. The feature set from each neonate was then correlated with the known outcome scales (either Sarnat or visually interpreted EEG, as described above) and a weighting matrix was calculated by linear least squares approximation. Channel 1 recordings formed the training database and were used to establish the baseline coefficients for the CHI/b features. Training was completed using Sarnat scores and then using visual interpretation of the EEG.
Testing of CHI/b
Channel 2 was used for the test database. The test database was independently graded by the electroencephalographer and was not used in the training process. Thus, the test data were unknown to the CHI/b matrix and could be treated as a cross-validation for its effectiveness.
The CHI/b values were calculated for the entire 30-min segment for each neonate. The CHI/b was calculated on moving 4-s windows with an overlap of 2 s, resulting in some smoothing of the output. The overall CHI/b value for each neonate was calculated as the average of all 4-s windows across the length of the recording.
Statistical methods
As our sample sizes were small, a Kruskal-Wallis one-way analysis of variance was used to test whether CHI/b was different across groups. This was followed with two-tailed Mann-Whitney U-tests. Further, a receiver operator characteristic (ROC) curve analysis was carried out to test the effectiveness of CHI/b as a classifier of brain injury. All statistical analysis was carried out assuming a significance level (a) of 0.05.
Results
The distribution of modified Sarnat scores among the 20 neonates with HIE was stage 1 HIE (n ¼ 3); stage 2 HIE (n ¼ 8); and stage 3 HIE (n ¼ 9). The mean ( þ s.d.) gestational age for all the neonates was 38.85 (±1.63) weeks. Figure 1 shows a box plot of CHI/b against the Sarnat classification for the testing data set. As seen, neonates with a Sarnat classification of 1 were the least injured clinically and indistinguishable from the control group. However, the CHI/b was able to distinguish between normal controls and abnormal clinical scores (babies with a Sarnat classification of 2 or 3). CHI/b had a higher average in neurologically normal neonates compared with those with HIE (P<0.02). A further statistical analysis of this data set was carried out using Kruskal-Wallis one-way analysis of variance. The Kruskal-Wallis test requires that each sample group have a minimum of five cases. As the Sarnat 1 had a smaller sample size (n ¼ 3), this group was eliminated from further analysis. The Kruskal-Wallis test showed that the means (CHI/b) of the three groups (Sarnat 2, 3 and controls) were not equal with P<0.02. To determine the differences in the means among the three groups, two-tailed Mann-Whitney U-tests were performed. The Mann-Whitney U-tests also showed that there was a statistically significant difference between CHI/b scores of controls vs Sarnat 2 (P<0.001) and controls vs Sarnat 3 (P<0.005). There was no significant difference in the mean CHI/b values of Sarnat 2 vs Sarnat 3.
CHI/b and Sarnat
Receiver operator characteristic curve analysis was carried out for the testing data set showing the sensitivity and specificity for discriminating between normal cases and abnormal clinical scores (defined as Sarnat 2 and 3) (Figure 2 ). The area under the curve, which represents the discriminatory ability of CHI/b, was 91.2%. A CHI/b value of 0.605 provided the optimal cutoff for identification of brain injury. A CHI/b value of <0.605 would represent a poor Sarnat score and vice versa. With this threshold, CHI/b has an overall sensitivity and specificity of 82.4 and 100% for differentiating a normal from abnormal Sarnat score. Figure 3 shows a box plot of CHI/b against visual EEG interpretation for the testing data set. CHI/b was able to distinguish between all the three EEG classifications. A statistical analysis of this data set was carried out to evaluate its ability to discriminate among the three groups (Kruskal-Wallis one-way analysis of variance, P<0.0002). There was a statistically significant difference in the normal vs mild (P<0.005), mild vs severe (P<0.01) and normal vs severe groups (P<0.005) as given by two-tailed Mann-Whitney U-tests. Thus, CHI/b was able to provide a good discrimination among the three groups.
CHI/b and visually interpreted EEG analysis
In addition, ROC curve analysis was carried out (Figure 4 
Discussion
Neonatal EEG often is considered one of the most multifaceted and therefore perplexing realizations of cortical potentials. The potential scope of injuries confronting the newborn infant leaves the EEG to be a bewildering 'signal-scape' with a host of waveform varieties. No single parameter can be expected to capture all of the nuances of the signal varieties that are evident. For this reason it is essential to have as many features as possible to fortify the classification strategy. The multiparametric approach used by the CHI/b algorithm utilizes a multifactorial decision-making/patternrecognition technique. In this study, CHI/b seems to be highly sensitive and specific in the identification of severe clinical encepaholpathy (Sarnat scores of 2 and 3) in at-risk newborn term infants. These results suggest that the bedside availability of CHI/b would also potentially allow for continuous monitoring during the course of recovery of the infant.
Using the gold standard of expert neurophysiologist interpretation of the neonatal EEG, CHI/b was shown to have high sensitivity and specificity for detecting severely abnormal EEG waveforms (that is, presence of any seizure or >2 min of continuous low-voltage or burst-suppression pattern). Bursting and inactive EEG patterns on the EEG are associated with a poor neurological condition. Thus, having a CHI/b measure of bursting and inactive EEG could potentially help in both the identification of the severity of injury and in tracking the recovery of the brain from HIE.
Amplitude-integrated EEG [14] [15] [16] [17] has been shown to have the ability to identify infants at risk. However, it requires training to interpret and does not provide an automated metric. Toet et al. 18 compared aEEG with standard conventional EEG and found that very short, low voltage and certain focal ictal activity was missed by aEEG. In addition, although aEEG is excellent in detecting either normal or severely abnormal babies, there is a lack of sensitivity for mild to moderate injury. Such infants may have the most to gain from any future neuroprotective therapy, and thus EEG metrics should be aimed to target these infants.
Although neuroprotective intervention after hypoxic-asphyxic insult is still an emerging field, further development and testing of CHI/b may prove it to be useful as a research tool for the early identification of appropriate subjects or candidates who may actually benefit from neuroprotection. In addition to real-time tracking of human neonatal hypoxic-ischemic brain injury, CHI/b may also be useful for monitoring the neonatal response to neuroprotective treatment if such treatment is provided. The ability of CHI/b to reliably indicate injury in this early analysis is exciting as such a tool could potentially help in the development and evaluation of neuroprotective strategies.
Our study is very preliminary. One major limitation was the lack of a truly independent data set for training and testing. Given that we did not have enough subjects in each group to divide the data into an independent training and testing data set, we present here the results of training on the left channel and testing on the right. It is possible that the channels may not be completely independent, and hence could lead to a deceptively stronger result. We are currently collecting more data in a prospective study that will use an independent training and testing database. Secondly, although the Sarnat scale is widely clinically used to assess ongoing clinical status of babies, its use as a long-term outcome measure may not be appropriate. For this reason, we compared the CHI/b with Sarnat, as well as to visual EEG grading as the gold standard. Thirdly, owing to constraints with clinical priorities, it was not possible to ensure that all EEG recordings were performed at the same time after birth. Although all EEG was collected within 72 h after birth, even this small variation will affect the EEG patterns after injury in the developing brain. As mentioned, we are currently undertaking a larger clinical study with a more rigorous protocol and with more appropriate neurological outcome measures and quantitative neuroimaging studies. The study is designed to collect 90-day and 180-day outcomes and will investigate the ability of CHI/b in predicting these long-term outcomes within the first 72 h. In this preliminary study, CHI/b, a novel multiparametric EEG-based index, seems to be able to identify newborns at risk for developing HIE. Larger studies will aid in the further development of CHI/b and confirm its utility as an objective tool for the assessment of neurological status of neonates. 
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